Xtrackers SPXD ETF offers a balanced way to invest in S&P 500 without relying on tech giants like Nvidia. Its innovative approach prioritizes actual economic activity and has affordable fees.

Dividend growth rates over a 5-year or longer period can be a good indicator of strong growth potential in picking a stock ...

Dividend Aristocrats are outperforming SPY in July but still trail year-to-date. Check out my Promising Aristocrats list here ...

It is hard to get excited after looking at Abbott Laboratories' (NYSE:ABT) recent performance, when its stock has declined 5.8% over the past month. However, a closer look at its sound financials ...

You should have around $100 or so remaining from your initial $350 after buying one share each of AbbVie and Dominion Energy.

Abbott Laboratories (NYSE:ABT) is included among the 10 Oversold Dividend Stocks to Buy According to Hedge Funds. The company reported strong earnings in the second quarter of 2025. It posted revenue ...

A majority of Americans have experienced the frustration of getting a healthcare insurance denial, often times finding no ...

HCA Healthcare, Inc. HCA reported second-quarter 2025 adjusted earnings per share (EPS) of $6.84, which surpassed the Zacks ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Abbott Laboratories might just be the prescription for your portfolio. The company is sitting pretty thanks to strong ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive surprises than negative ones. Companies had a lower bar to clear coming into the ...

While Abbott Laboratories' stock dips by 5.5% over the past month, a closer look reveals robust fundamentals hinting at ...